Acadia Pharmaceutica (ACAD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2020 | 06-2020 | 03-2020 | 12-2019 | 09-2019 | |
| Sales | 120,577 | 110,103 | 90,068 | 98,326 | 94,586 |
| Cost of Goods | 2,005 | 2,899 | 2,799 | 3,020 | 2,416 |
| Gross Profit | 118,572 | 107,204 | 87,269 | 95,306 | 92,170 |
| Operating Expenses | 204,476 | 152,113 | 177,583 | 151,725 | 138,007 |
| Operating Income | -85,899 | -44,010 | -89,515 | -56,399 | -45,421 |
| Other Income | 1,040 | 2,262 | 1,492 | 3,763 | 3,179 |
| Pre-tax Income | -84,859 | -41,748 | -88,023 | -52,636 | -42,242 |
| Income Tax | -199 | 393 | N/A | 400 | -264 |
| Net Income Continuous | -84,660 | -42,141 | -88,023 | -53,036 | -41,978 |
| Net Income | $-84,660 | $-42,141 | $-88,023 | $-53,036 | $-41,978 |
| EPS Basic Total Ops | -0.54 | -0.27 | -0.57 | -0.34 | -0.29 |
| EPS Basic Continuous Ops | -0.54 | -0.27 | -0.57 | -0.34 | -0.29 |
| EPS Diluted Total Ops | -0.54 | -0.27 | -0.57 | -0.34 | -0.29 |
| EPS Diluted Continuous Ops | -0.54 | -0.27 | -0.57 | -0.34 | -0.29 |
| EBITDA(a) | $-84,852 | $-42,893 | $-88,764 | $-56,325 | $-45,827 |